Market Tracker

02/12 5:16pm ET

Mylan NV (NASDAQ:MYL)

41.83
Delayed Data
As of Feb 12
 +0.405 / +0.98%
Today’s Change
37.59
Today|||52-Week Range
76.69
-22.65%
Year-to-Date

Today’s Trading

Previous close41.42
Today’s open41.34
Day’s range40.05 - 42.00
Volume15,531,140
Average volume (3 months)7,751,240
Market cap$20.6B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+14.82%
Earnings growth (next 5 years)+11.62%
Revenue growth (last year)+21.39%
P/E ratio18.0
Price/Sales2.85
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+3.52+4.42%
PRGOPerrigo Company PLC+3.53+2.61%
ZTSZoetis Inc+1.07+2.72%
INCYIncyte Corp+2.85+4.35%
Data as of 4:02pm ET, 02/12/2016

Financials

Next reporting dateApril 28, 2016
EPS forecast (this quarter)$0.87
Annual revenue (last year)$9.4B
Annual profit (last year)$847.6M
Net profit margin8.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Potters Bar, Hertfordshire

Forecasts